Microtubules	microtubule	NNS	O
composed	compose	VBN	O
of	of	IN	O
Î±-tubulin	Î±-tubulin	NNP	O
and	and	CC	O
Î²-tubulin	Î²-tubulin	NNP	O
heterodimers	heterodimer	NNS	O
are	be	VBP	O
essential	essential	JJ	O
components	component	NNS	O
of	of	IN	O
the	the	DT	O
cytoskeleton	cytoskeleton	NN	O
of	of	IN	O
eukaryotic	eukaryotic	JJ	O
cells	cell	NNS	O
,	,	,	O
and	and	CC	O
they	-PRON-	PRP	O
play	play	VBP	O
important	important	JJ	O
roles	role	NNS	O
in	in	IN	O
a	a	DT	O
series	series	NN	O
of	of	IN	O
cellular	cellular	JJ	O
processes	process	NNS	O
such	such	JJ	O
as	as	IN	O
determination	determination	NN	O
and	and	CC	O
maintenance	maintenance	NN	O
of	of	IN	O
cell	cell	NN	O
shape	shape	NN	O
,	,	,	O
regulation	regulation	NN	O
of	of	IN	O
motility	motility	NN	O
,	,	,	O
organisation	organisation	NN	O
of	of	IN	O
intracellular	intracellular	NNP	O
architecture	architecture	NN	O
,	,	,	O
secretion	secretion	NN	O
,	,	,	O
cellular	cellular	JJ	O
transport	transport	NN	O
,	,	,	O
and	and	CC	O
cell	cell	NN	O
division	division	NN	B
,	,	,	B
.	.	.	O

Over	over	IN	O
the	the	DT	O
past	past	JJ	O
two	two	CD	O
decades	decade	NNS	O
,	,	,	O
microtubule	microtubule	NNP	O
has	have	VBZ	O
been	be	VBN	O
recognised	recognise	VBN	O
as	as	IN	O
an	an	DT	O
attractive	attractive	JJ	O
target	target	NN	O
for	for	IN	O
developing	develop	VBG	O
chemotherapeutic	chemotherapeutic	JJ	O
drugs	drug	NNS	O
to	to	TO	O
treat	treat	VB	O
cancer	cancer	NN	O
due	due	IN	O
to	to	IN	O
its	-PRON-	PRP$	O
important	important	JJ	O
roles	role	NNS	O
in	in	IN	O
the	the	DT	O
life	life	NN	O
cycle	cycle	NN	O
of	of	IN	O
the	the	DT	O
cell	cell	NN	B
.	.	.	O

Therefore	therefore	RB	O
,	,	,	O
discovery	discovery	NN	O
and	and	CC	O
development	development	NN	O
of	of	IN	O
new	new	JJ	O
tubulin	tubulin	NN	O
polymerisation	polymerisation	NN	O
inhibitors	inhibitor	NNS	O
has	have	VBZ	O
attracted	attract	VBN	O
great	great	JJ	O
attention	attention	NN	O
in	in	IN	O
recent	recent	JJ	O
years	year	NNS	O
.	.	.	O

Chalcones	chalcone	NNS	O
are	be	VBP	O
an	an	DT	O
important	important	JJ	O
class	class	NN	O
of	of	IN	O
natural	natural	JJ	O
compounds	compound	NNS	O
belonging	belong	VBG	O
to	to	IN	O
the	the	DT	O
flavonoid	flavonoid	JJ	O
family	family	NN	O
,	,	,	O
which	which	WDT	O
have	have	VBP	O
two	two	CD	O
aromatic	aromatic	JJ	O
rings	ring	NNS	O
are	be	VBP	O
linked	link	VBN	O
by	by	IN	O
a	a	DT	O
three	three	CD	O
carbon	carbon	NN	O
Î±	î±	NN	O
,	,	,	O
Î²-unsaturated	î²-unsaturate	VBN	O
carbonyl	carbonyl	NN	O
system	system	NN	O
.	.	.	O

Chalcones	chalcone	NNS	O
and	and	CC	O
derivatives	derivative	NNS	O
received	receive	VBD	O
significant	significant	JJ	O
attention	attention	NN	O
since	since	IN	O
their	-PRON-	PRP$	O
have	have	VBP	O
diverse	diverse	JJ	O
and	and	CC	O
interesting	interesting	JJ	O
biological	biological	JJ	O
properties	property	NNS	O
such	such	JJ	O
as	as	IN	O
antifungal	antifungal	JJ	O
,	,	,	O
anti	anti	JJ	O
-	-	JJ	O
inflammatory	inflammatory	JJ	O
,	,	,	O
antituberculosis	antituberculosis	NN	O
,	,	,	O
antihyperglycemic	antihyperglycemic	JJ	O
,	,	,	O
antimalarial	antimalarial	JJ	O
,	,	,	O
antileishmanial	antileishmanial	JJ	O
,	,	,	O
and	and	CC	O
anticancer	anticancer	NN	B
.	.	.	O

More	more	RBR	O
particularly	particularly	RB	O
,	,	,	O
a	a	DT	O
number	number	NN	O
of	of	IN	O
synthetic	synthetic	JJ	O
and	and	CC	O
natural	natural	JJ	O
chalcones	chalcone	NNS	O
exhibited	exhibit	VBD	O
potent	potent	JJ	O
anticancer	anticancer	NN	O
activity	activity	NN	O
against	against	IN	O
many	many	JJ	O
cancer	cancer	NN	O
cell	cell	NN	O
lines	line	NNS	O
via	via	IN	O
inhibition	inhibition	NN	O
of	of	IN	O
tubulin	tubulin	JJ	O
polymerization	polymerization	NN	B
.	.	.	O

Many	many	JJ	O
previous	previous	JJ	O
studies	study	NNS	O
have	have	VBP	O
shown	show	VBN	O
that	that	IN	O
the	the	DT	O
presence	presence	NN	O
of	of	IN	O
a	a	DT	O
2â²-hydroxyl	2â²-hydroxyl	CD	O
group	group	NN	O
on	on	IN	O
the	the	DT	O
A	a	NN	O
-	-	HYPH	O
ring	ring	NN	O
is	be	VBZ	O
important	important	JJ	O
for	for	IN	O
the	the	DT	O
antitumor	antitumor	NN	O
activity	activity	NN	O
of	of	IN	O
chalcone	chalcone	NN	O
derivatives	derivative	VBZ	B
.	.	.	O

For	for	IN	O
example	example	NN	O
,	,	,	O
Shin	Shin	NNP	O
etÂ	etÂ	NNP	O
al	al	NNP	O
.	.	NNP	O

reported	report	VBD	O
the	the	DT	O
synthesis	synthesis	NN	O
of	of	IN	O
2-hydroxy-4-methoxy-2â²,3â²-benzochalcone	2-hydroxy-4-methoxy-2â²,3â²-benzochalcone	CD	O
which	which	WDT	O
exhibited	exhibit	VBD	O
antiproliferative	antiproliferative	JJ	O
activity	activity	NN	O
in	in	IN	O
several	several	JJ	O
human	human	JJ	O
solid	solid	JJ	O
tumour	tumour	NN	O
cell	cell	NN	O
lines	line	NNS	O
and	and	CC	O
suppressed	suppress	VBD	O
xenografted	xenografted	NNP	O
tumour	tumour	NN	O
growth	growth	NN	O
in	in	IN	O
nude	nude	JJ	O
mice	mouse	NNS	O
Figure	figure	NN	O
1	1	CD	O
.	.	.	O

Additionally	additionally	RB	O
,	,	,	O
mechanistic	mechanistic	JJ	O
studies	study	NNS	O
showed	show	VBD	O
that	that	IN	O
it	-PRON-	PRP	O
can	can	MD	O
induced	induce	VBN	O
cell	cell	NN	O
cycle	cycle	NN	O
arrest	arrest	NN	O
at	at	IN	O
the	the	DT	O
G2	G2	NNP	O
/	/	SYM	O
M	M	NNP	O
phase	phase	NN	O
and	and	CC	O
increased	increase	VBD	O
in	in	IN	O
apoptotic	apoptotic	JJ	O
cell	cell	NN	O
death	death	NN	O
through	through	IN	O
the	the	DT	O
inhibition	inhibition	NN	O
of	of	IN	O
tubulin	tubulin	JJ	O
polymerization	polymerization	NN	B
.	.	.	O

Lee	Lee	NNP	O
etÂ	etÂ	NNP	O
al	al	NNP	O
reported	report	VBD	O
the	the	DT	O
synthesis	synthesis	NN	O
of	of	IN	O
2â²-hydroxy-5â²,6â²-naphthochalcone	2â²-hydroxy-5â²,6â²-naphthochalcone	CD	O
derivatives	derivative	NNS	O
and	and	CC	O
the	the	DT	O
most	most	RBS	O
active	active	JJ	O
compound	compound	NN	O
was	be	VBD	O
found	find	VBN	O
to	to	TO	O
be	be	VB	O
strongly	strongly	RB	O
inhibited	inhibit	VBN	O
the	the	DT	O
clonogenicity	clonogenicity	NN	O
of	of	IN	O
SW620	sw620	JJ	O
colon	colon	NN	O
cancer	cancer	NN	O
cells	cell	NNS	O
Figure	figure	NN	O
1	1	CD	O
.	.	.	O

Mechanistically	mechanistically	RB	O
,	,	,	O
HMNC-74	hmnc-74	CD	O
triggered	trigger	VBN	O
cell	cell	NN	O
cycle	cycle	NN	O
arrest	arrest	NN	O
at	at	IN	O
G2	G2	NNP	O
/	/	SYM	O
M	M	NNP	O
phase	phase	NN	O
and	and	CC	O
apoptosis	apoptosis	NN	O
by	by	IN	O
disrupting	disrupt	VBG	O
the	the	DT	O
microtubular	microtubular	JJ	O
network	network	NN	B
.	.	.	O

Structures	structure	NNS	O
of	of	IN	O
chalcone	chalcone	NN	O
and	and	CC	O
compounds	compound	NNS	O
IâV.	IâV.	NNP	O
One	one	CD	O
the	the	DT	O
other	other	JJ	O
hand	hand	NN	O
,	,	,	O
many	many	JJ	O
researchers	researcher	NNS	O
think	think	VBP	O
that	that	IN	O
chalcones	chalcone	NNS	O
possessed	possess	VBD	O
significant	significant	JJ	O
anticancer	anticancer	NN	O
activity	activity	NN	O
due	due	JJ	O
to	to	IN	O
their	-PRON-	PRP$	O
have	have	VBP	O
a	a	DT	O
similar	similar	JJ	O
mode	mode	NN	O
of	of	IN	O
action	action	NN	O
to	to	IN	O
the	the	DT	O
structurally	structurally	RB	O
related	relate	VBN	O
natural	natural	JJ	O
combretastatin	combretastatin	NN	O
A-4	A-4	NNP	B
,	,	,	O
and	and	CC	O
the	the	DT	O
methoxy	methoxy	JJ	O
substituent	substituent	NN	O
in	in	IN	O
A	a	DT	O
ring	ring	NN	O
is	be	VBZ	O
a	a	DT	O
crucial	crucial	JJ	O
pharmacophoric	pharmacophoric	JJ	O
group	group	NN	O
for	for	IN	O
the	the	DT	O
anticancer	anticancer	NN	O
potency	potency	NN	O
by	by	IN	O
inhibition	inhibition	NN	O
of	of	IN	O
tubulin	tubulin	JJ	O
polymerisation	polymerisation	NN	O
Figure	Figure	NNP	O
1(IIIâV	1(IIIâV	NNP	O
)	)	-RRB-	B
.	.	.	O

Moreover	moreover	RB	O
,	,	,	O
introduction	introduction	NN	O
of	of	IN	O
different	different	JJ	O
substituents	substituent	NNS	O
on	on	IN	O
aromatic	aromatic	JJ	O
rings	ring	NNS	O
of	of	IN	O
chalcone	chalcone	NN	O
can	can	MD	O
bring	bring	VB	O
the	the	DT	O
significant	significant	JJ	O
changes	change	NNS	O
in	in	IN	O
anticancer	anticancer	NN	O
activity	activity	NN	O
.	.	.	O

Based	base	VBN	O
on	on	IN	O
the	the	DT	O
studies	study	NNS	O
discussed	discuss	VBN	O
above	above	RB	O
,	,	,	O
we	-PRON-	PRP	O
decided	decide	VBD	O
to	to	TO	O
report	report	VB	O
the	the	DT	O
the	the	DT	O
synthesis	synthesis	NN	O
of	of	IN	O
naphthalene	naphthalene	NN	O
-	-	HYPH	O
chalcone	chalcone	NN	O
derivatives	derivative	NNS	O
containing	contain	VBG	O
2â²-methoxyl	2â²-methoxyl	CD	O
in	in	IN	O
the	the	DT	O
A	A	NNP	O
ring	ring	NN	O
based	base	VBN	O
on	on	IN	O
lead	lead	JJ	O
compound	compound	NN	O
HMNC-74	hmnc-74	CD	O
.	.	.	O

The	the	DT	O
synthesised	synthesise	VBN	O
compounds	compound	NNS	O
were	be	VBD	O
evaluated	evaluate	VBN	O
for	for	IN	O
their	-PRON-	PRP$	O
anticancer	anticancer	NN	O
activity	activity	NN	O
.	.	.	O

Rationale	rationale	NN	O
design	design	NN	O
of	of	IN	O
the	the	DT	O
title	title	NN	O
compounds	compound	NNS	O
of	of	IN	O
this	this	DT	O
study	study	NN	O
.	.	.	O

The	the	DT	O
synthesis	synthesis	NN	O
route	route	NN	O
of	of	IN	O
naphthalene	naphthalene	NN	O
-	-	HYPH	O
chalcone	chalcone	NN	O
derivatives	derivative	NNS	O
3aâ3	3aâ3	NNPS	O
t	t	NN	O
was	be	VBD	O
shown	show	VBN	O
in	in	IN	O
Scheme	Scheme	NNP	O
1	1	CD	O
.	.	.	O

Compound	Compound	NNP	O
2	2	CD	O
was	be	VBD	O
prepared	prepare	VBN	O
by	by	IN	O
alkylation	alkylation	NN	O
of	of	IN	O
1âethan-1-one	1âethan-1-one	CD	O
in	in	IN	O
classical	classical	JJ	O
conditions	condition	NNS	O
using	use	VBG	O
methyl	methyl	NN	O
iodide	iodide	NN	O
in	in	IN	O
the	the	DT	O
presence	presence	NN	O
of	of	IN	O
Cs2CO3	Cs2CO3	NNP	O
in	in	IN	O
dry	dry	JJ	O
acetone	acetone	NN	O
.	.	.	O

Condensation	condensation	NN	O
of	of	IN	O
2	2	CD	O
with	with	IN	O
a	a	DT	O
variety	variety	NN	O
of	of	IN	O
commercially	commercially	RB	O
available	available	JJ	O
aryl	aryl	NNP	O
aldehydes	aldehyde	NNS	O
in	in	IN	O
the	the	DT	O
presence	presence	NN	O
of	of	IN	O
KOH	KOH	NNP	O
at	at	IN	O
room	room	NN	O
temperature	temperature	NN	O
to	to	TO	O
provide	provide	VB	O
the	the	DT	O
target	target	NN	O
compounds	compound	NNS	O
3aâ3	3aâ3	NNPS	O
t	t	NN	O
,	,	,	O
which	which	WDT	O
were	be	VBD	O
characterised	characterise	VBN	O
by	by	IN	O
1H	1h	JJ	O
NMR	NMR	NNP	O
,	,	,	O
13C	13C	NNP	O
NMR	NMR	NNP	O
,	,	,	O
and	and	CC	O
HRMS	HRMS	NNP	O
.	.	.	O

The	the	DT	O
1H	1h	JJ	O
NMR	NMR	NNP	O
of	of	IN	O
compound	compound	NNP	O
3a	3a	NNP	O
shows	show	VBZ	O
two	two	CD	O
doublets	doublet	NNS	O
Î´â=â6.96	î´â=â6.96	NN	O
and	and	CC	O
7.21âppm	7.21âppm	NNP	O
with	with	IN	O
coupling	couple	VBG	O
constants	constant	NNS	O
Jâ=â16.0âHz	Jâ=â16.0âHz	NNP	O
for	for	IN	O
the	the	DT	O
olefin	olefin	JJ	O
hydrogen	hydrogen	NN	O
of	of	IN	O
Î±	Î±	NNP	O
,	,	,	O
Î²-unsaturated	î²-unsaturate	VBD	O
ketone	ketone	NN	O
.	.	.	O

The	the	DT	O
protons	proton	NNS	O
of	of	IN	O
3-hydroxyl-4-methoxy	3-hydroxyl-4-methoxy	CD	O
phenyl	phenyl	NN	O
moiety	moiety	NN	O
were	be	VBD	O
appeared	appear	VBN	O
as	as	IN	O
two	two	CD	O
doublets	doublet	NNS	O
for	for	IN	O
one	one	CD	O
proton	proton	NNP	O
each	each	DT	O
at	at	IN	O
Î	Î	NNP	O
´	´	NNP	O
6.78âppm	6.78âppm	CD	O
and	and	CC	O
Î	Î	NNP	O
´	´	NNP	O
7.16âppm	7.16âppm	NNP	O
with	with	IN	O
the	the	DT	O
coupling	couple	VBG	O
constants	constant	NNS	O
Jâ=â8.0âHz	Jâ=â8.0âHz	NNP	O
and	and	CC	O
2.0âHz	2.0âhz	CD	O
,	,	,	O
respectively	respectively	RB	O
and	and	CC	O
a	a	DT	O
doublet	doublet	NN	O
of	of	IN	O
doublets	doublet	NNS	O
of	of	IN	O
one	one	CD	O
proton	proton	NNP	O
at	at	IN	O
Î	Î	NNP	O
´	´	NNP	O
6.95âppm	6.95âppm	NNP	O
Jâ=â8.0âHz	Jâ=â8.0âHz	NNP	O
and	and	CC	O
2.0âHz	2.0âHz	NNP	O
.	.	.	O

The	the	DT	O
remaining	remain	VBG	O
aryl	aryl	NNP	O
protons	proton	NNS	O
were	be	VBD	O
appeared	appear	VBN	O
as	as	IN	O
two	two	CD	O
multiplets	multiplet	NNS	O
for	for	IN	O
two	two	CD	O
protons	proton	NNS	O
between	between	IN	O
Î	Î	NNP	O
´	´	CD	O
7.35â7.44âppm	7.35â7.44âppm	CD	O
and	and	CC	O
four	four	CD	O
doublets	doublet	NNS	O
for	for	IN	O
one	one	CD	O
proton	proton	NNP	O
each	each	DT	O
at	at	IN	O
Î	Î	NNP	O
´	´	CD	O
7.31	7.31	CD	O
,	,	,	O
7.66	7.66	CD	O
,	,	,	O
7.80	7.80	CD	O
and	and	CC	O
7.91âppm	7.91âppm	NNP	O
with	with	IN	O
the	the	DT	O
J	J	NNP	O
values	value	NNS	O
8.8	8.8	CD	O
,	,	,	O
8.4	8.4	CD	O
,	,	,	O
8.0	8.0	CD	O
,	,	,	O
and	and	CC	O
8.8âHz	8.8âHz	NNP	O
,	,	,	O
respectively	respectively	RB	O
.	.	.	O

The	the	DT	O
methoxyl	methoxyl	JJ	O
protons	proton	NNS	O
of	of	IN	O
OCH3	OCH3	NNP	O
appeared	appear	VBD	O
as	as	IN	O
two	two	CD	O
singlets	singlet	NNS	O
at	at	IN	O
3.89	3.89	CD	O
and	and	CC	O
3.91âppm	3.91âppm	NNP	O
.	.	.	O

The	the	DT	O
single	single	JJ	O
peak	peak	NN	O
of	of	IN	O
OH	OH	NNP	O
proton	proton	NNP	O
was	be	VBD	O
observed	observe	VBN	O
at	at	IN	O
Î	Î	NNP	O
´	´	CD	O
5.64âppm	5.64âppm	CD	O
.	.	.	O

The	the	DT	O
13C	13C	NNP	O
NMR	NMR	NNP	O
of	of	IN	O
compound	compound	NNP	O
3a	3a	NNP	O
shows	show	VBZ	O
the	the	DT	O
carbonyl	carbonyl	NN	O
carbon	carbon	NN	O
appeared	appear	VBD	O
at	at	IN	O
197.53âppm	197.53âppm	CD	O
.	.	.	O

The	the	DT	O
signals	signal	NNS	O
of	of	IN	O
two	two	CD	O
methoxyls	methoxyls	NN	O
appeared	appear	VBD	O
at	at	IN	O
Î	Î	NNP	O
´	´	CD	O
56.10	56.10	CD	O
and	and	CC	O
56.75â¯ppm	56.75â¯ppm	CD	O
.	.	.	O

The	the	DT	O
remaining	remain	VBG	O
aromatic	aromatic	JJ	O
and	and	CC	O
olefin	olefin	JJ	O
carbons	carbon	NNS	O
resonates	resonate	VBZ	O
around	around	IN	O
Î	Î	NNP	O
´	´	CD	O
110.55â154.09â¯ppm	110.55â154.09â¯ppm	CD	O
.	.	.	O

The	the	DT	O
high	high	JJ	O
-	-	HYPH	O
resolution	resolution	NN	O
mass	mass	NN	O
spectrum	spectrum	NN	O
of	of	IN	O
compound	compound	NNP	O
3a	3a	NNP	O
showed	show	VBD	O
a	a	DT	O
molecular	molecular	JJ	O
ion	ion	NN	O
peak	peak	NN	O
at	at	IN	O
m	m	NNP	O
/	/	SYM	O
z	z	NNP	O
389.0149	389.0149	NN	O
as	as	IN	O
Mâ+âNa]+	mâ+âna]+	CD	O
which	which	WDT	O
also	also	RB	O
supports	support	VBZ	O
the	the	DT	O
proposed	propose	VBN	O
structure	structure	NN	O
of	of	IN	O
the	the	DT	O
compound	compound	NN	O
.	.	.	O

Similar	similar	JJ	O
pattern	pattern	NN	O
was	be	VBD	O
observed	observe	VBN	O
in	in	IN	O
1H	1h	JJ	O
NMR	NMR	NNP	O
and	and	CC	O
13C	13C	NNP	O
NMR	NMR	NNP	O
spectroscopy	spectroscopy	NN	O
of	of	IN	O
all	all	PDT	O
the	the	DT	O
title	title	NN	O
compounds	compound	VBZ	O
3aâ3	3aâ3	,	O
t	t	NN	O
.	.	.	O

The	the	DT	O
HRMS	HRMS	NNP	O
of	of	IN	O
all	all	PDT	O
the	the	DT	O
compounds	compound	NNS	O
3aâ3	3aâ3	,	O
t	t	NNP	O
showed	show	VBD	O
a	a	DT	O
molecular	molecular	JJ	O
ion	ion	NN	O
peak	peak	NN	O
equivalent	equivalent	JJ	O
to	to	IN	O
their	-PRON-	PRP$	O
molecular	molecular	JJ	O
formulae	formula	NNS	O
.	.	.	O

Scheme	scheme	NN	O
of	of	IN	O
synthesis	synthesis	NN	O
of	of	IN	O
target	target	NN	O
compounds	compound	NNS	O
3aâ3	3aâ3	NNPS	O
t	t	NN	O
.	.	.	O

Reagents	reagent	NNS	O
and	and	CC	O
conditions	condition	NNS	O
:	:	:	O
Cs2CO3	Cs2CO3	NNP	O
,	,	,	O
acetone	acetone	NNP	O
,	,	,	O
r.t	r.t	NNP	O
.	.	NNP	O

12âh	12âh	CD	O
;	;	:	O
50	50	CD	O
%	%	NN	O
KOH	KOH	NNP	O
,	,	,	O
MeOH	MeOH	NNP	O
,	,	,	O
0âÂ	0ââ	CD	O
°	°	,	O
C	C	NNP	O
,	,	,	O
0.5âh	0.5âh	CD	O
to	to	IN	O
r.t	r.t	NNP	O
.	.	NNP	O

,	,	,	O
24âh	24âh	CD	O
.	.	.	O

All	all	PDT	O
the	the	DT	O
synthesised	synthesise	VBN	O
naphthalene	naphthalene	NN	O
-	-	HYPH	O
chalcone	chalcone	NN	O
derivatives	derivative	NNS	O
3aâ3	3aâ3	NNPS	O
t	t	NN	O
were	be	VBD	O
evaluated	evaluate	VBN	O
for	for	IN	O
their	-PRON-	PRP$	O
anticancer	anticancer	NN	O
activity	activity	NN	O
by	by	IN	O
3	3	CD	O
-	-	HYPH	O
-2,5-diphenyltetrazolium	-2,5-diphenyltetrazolium	NNP	O
bromide	bromide	NN	O
assay	assay	NN	O
method	method	NN	O
against	against	IN	O
human	human	JJ	O
breast	breast	NN	O
carcinoma	carcinoma	NN	O
cell	cell	NN	O
line	line	NN	O
MCF-7	MCF-7	NNP	O
.	.	.	O

Cisplatin	Cisplatin	NNP	O
was	be	VBD	O
used	use	VBN	O
as	as	IN	O
a	a	DT	O
reference	reference	NN	O
drug	drug	NN	O
.	.	.	O

The	the	DT	O
results	result	NNS	O
were	be	VBD	O
expressed	express	VBN	O
as	as	IN	O
the	the	DT	O
IC50	IC50	NNP	O
.	.	.	O

As	as	IN	O
shown	show	VBN	O
in	in	IN	O
Table	table	NN	O
1	1	CD	O
,	,	,	O
most	most	JJS	O
of	of	IN	O
the	the	DT	O
tested	test	VBN	O
compounds	compound	NNS	O
displayed	display	VBD	O
potent	potent	JJ	O
antiproliferative	antiproliferative	JJ	O
activity	activity	NN	O
with	with	IN	O
IC50	IC50	NNP	O
values	value	NNS	O
ranging	range	VBG	O
from	from	IN	O
1.42âÂ±â0.15	1.42ââ±â0.15	CD	O
to	to	IN	O
>	>	XX	O
10âÂµM.	10ââµm.	CD	O
Among	among	IN	O
these	these	DT	O
compounds	compound	NNS	O
,	,	,	O
compounds	compound	NNS	O
3c	3c	NNP	O
and	and	CC	O
3j	3j	NNP	O
were	be	VBD	O
found	find	VBN	O
to	to	TO	O
be	be	VB	O
inactive	inactive	JJ	O
toward	toward	IN	O
MCF-7	mcf-7	JJ	O
cell	cell	NN	O
line	line	NN	O
IC50	IC50	NNP	O
>	>	XX	O
10âÂµM	10ââµm	CD	O
.	.	.	O

All	all	DT	O
other	other	JJ	O
tested	test	VBN	O
compounds	compound	NNS	O
shown	show	VBN	O
low	low	JJ	O
-	-	HYPH	O
micromole	micromole	NN	O
IC50	IC50	NNP	O
values	value	NNS	O
IC50	IC50	NNP	O
<	<	NNP	O
10âÂµM	10âÂµM	NNP	O
.	.	.	O

Particularly	particularly	RB	O
,	,	,	O
compounds	compound	VBZ	O
3a	3a	CD	O
and	and	CC	O
3	3	CD	O
t	t	NN	O
displayed	display	VBD	O
the	the	DT	O
most	most	RBS	O
potent	potent	JJ	O
antiproliferative	antiproliferative	JJ	O
activity	activity	NN	O
with	with	IN	O
IC50	IC50	NNP	O
values	value	NNS	O
of	of	IN	O
1.42âÂ±â0.15	1.42ââ±â0.15	CD	O
and	and	CC	O
2.75âÂ±â0.26âÂµM	2.75ââ±â0.26ââµm	CD	O
,	,	,	O
respectively	respectively	RB	O
.	.	.	O

Anticancer	anticancer	NN	O
activity	activity	NN	O
of	of	IN	O
compounds	compound	NNS	O
3aâ3	3aâ3	,	O
t	t	NN	O
against	against	IN	O
MCF-7	mcf-7	JJ	O
cell	cell	NN	O
line	line	NN	O
.	.	.	O

Analysis	analysis	NN	O
of	of	IN	O
structure	structure	NN	O
-	-	HYPH	O
activity	activity	NN	O
relationship	relationship	NN	O
of	of	IN	O
this	this	DT	O
class	class	NN	O
of	of	IN	O
compounds	compound	NNS	O
revealed	reveal	VBD	O
that	that	IN	O
the	the	DT	O
substituents	substituent	NNS	O
of	of	IN	O
aryl	aryl	NNP	O
ring	re	VBG	O
have	have	VBP	O
influences	influence	NNS	O
on	on	IN	O
their	-PRON-	PRP$	O
antiproliferative	antiproliferative	JJ	O
activities	activity	NNS	O
.	.	.	O

Introduction	introduction	NN	O
of	of	IN	O
halogen	halogen	NNP	O
group	group	NN	O
at	at	IN	O
para	para	NNP	O
position	position	NN	O
of	of	IN	O
phenyl	phenyl	NN	O
ring	ring	NN	O
results	result	NNS	O
in	in	IN	O
a	a	DT	O
slight	slight	JJ	O
increase	increase	NN	O
of	of	IN	O
the	the	DT	O
biological	biological	JJ	O
activity	activity	NN	O
.	.	.	O

However	however	RB	O
,	,	,	O
shifting	shift	VBG	O
these	these	DT	O
group	group	NN	O
to	to	IN	O
the	the	DT	O
2-	2-	NNP	O
or	or	CC	O
3-	3-	DT	O
position	position	NN	O
decreased	decrease	VBD	O
the	the	DT	O
biological	biological	JJ	O
activity	activity	NN	O
.	.	.	O

Furthermore	furthermore	RB	O
,	,	,	O
the	the	DT	O
replacement	replacement	NN	O
of	of	IN	O
the	the	DT	O
4-Br	4-br	CD	O
or	or	CC	O
4-Cl	4-cl	CD	O
substitutes	substitute	NNS	O
with	with	IN	O
dialkylamine	dialkylamine	NN	O
group	group	NNP	O
resulted	result	VBD	O
in	in	IN	O
a	a	DT	O
decrease	decrease	NN	O
of	of	IN	O
the	the	DT	O
inhibitory	inhibitory	JJ	O
activity	activity	NN	O
.	.	.	O

The	the	DT	O
replacement	replacement	NN	O
of	of	IN	O
the	the	DT	O
right	right	JJ	O
phenyl	phenyl	NNP	O
ring	ring	NN	O
with	with	IN	O
thiophene	thiophene	NN	O
resulted	result	VBD	O
in	in	IN	O
dramatically	dramatically	RB	O
decrease	decrease	NN	O
of	of	IN	O
antiproliferative	antiproliferative	JJ	O
activity	activity	NN	O
.	.	.	O

Among	among	IN	O
the	the	DT	O
series	series	NN	O
,	,	,	O
3-OH-4-OMe	3-oh-4-ome	CD	O
derivative	derivative	JJ	O
and	and	CC	O
3-NH2	3-nh2	CD	O
-	-	HYPH	O
4-OMe	4-ome	CD	O
derivative	derivative	NN	O
were	be	VBD	O
found	find	VBN	O
to	to	TO	O
be	be	VB	O
the	the	DT	O
most	most	RBS	O
active	active	JJ	O
compound	compound	NN	O
,	,	,	O
with	with	IN	O
IC50	IC50	NNP	O
values	value	NNS	O
of	of	IN	O
1.42âÂ±â0.15	1.42ââ±â0.15	CD	O
and	and	CC	O
2.75âÂ±â0.26âÂµM	2.75ââ±â0.26ââµm	CD	O
,	,	,	O
respectively	respectively	RB	O
.	.	.	O

Additionally	additionally	RB	O
,	,	,	O
compound	compound	NNP	O
3a	3a	NNP	O
IC50â=â1.42âÂ±â0.15âÂµM	IC50â=â1.42âÂ±â0.15âÂµM	NNP	O
with	with	IN	O
3-hydroxyl-4-methoxy	3-hydroxyl-4-methoxy	JJ	O
phenyl	phenyl	NNP	O
moiety	moiety	NN	O
was	be	VBD	O
found	find	VBN	O
to	to	TO	O
be	be	VB	O
the	the	DT	O
most	most	RBS	O
active	active	JJ	O
compound	compound	NN	O
.	.	.	O

In	in	IN	O
order	order	NN	O
to	to	TO	O
verify	verify	VB	O
the	the	DT	O
safety	safety	NN	O
profile	profile	NN	O
of	of	IN	O
this	this	DT	O
class	class	NN	O
of	of	IN	O
compounds	compound	NNS	O
,	,	,	O
the	the	DT	O
most	most	RBS	O
potent	potent	JJ	O
compound	compound	NNP	O
3a	3a	NNP	O
was	be	VBD	O
selected	select	VBN	O
to	to	TO	O
test	test	VB	O
its	-PRON-	PRP$	O
cytotoxicity	cytotoxicity	NN	O
against	against	IN	O
human	human	JJ	O
embryonic	embryonic	JJ	O
kidney	kidney	NN	O
cell	cell	NN	O
line	line	NN	O
in	in	IN	O
comparison	comparison	NN	O
to	to	TO	O
reference	reference	VB	O
drug	drug	NN	O
cisplatin	cisplatin	NN	O
.	.	.	O

As	as	IN	O
presented	present	VBN	O
in	in	IN	O
Table	Table	NNP	O
2	2	CD	O
,	,	,	O
compound	compound	NNP	O
3a	3a	NNP	O
exhibited	exhibit	VBD	O
cytotoxic	cytotoxic	NN	O
activity	activity	NN	O
against	against	IN	O
normal	normal	JJ	O
HEK293	HEK293	NNP	O
cells	cell	NNS	O
with	with	IN	O
IC50	IC50	NNP	O
value	value	NN	O
of	of	IN	O
18.3âÂ±â1.3âÂµM	18.3ââ±â1.3ââµm	CD	O
,	,	,	O
as	as	IN	O
compared	compare	VBN	O
to	to	TO	O
cisplatin	cisplatin	VB	O
IC50â=â5.3âÂ±â0.4âÂµM	IC50â=â5.3âÂ±â0.4âÂµM	NNP	O
.	.	.	O

Hence	hence	RB	O
,	,	,	O
we	-PRON-	PRP	O
could	could	MD	O
conclude	conclude	VB	O
that	that	IN	O
these	these	DT	O
compounds	compound	NNS	O
have	have	VBP	O
good	good	JJ	O
safety	safety	NN	O
for	for	IN	O
potential	potential	JJ	O
application	application	NN	O
in	in	IN	O
the	the	DT	O
treatment	treatment	NN	O
of	of	IN	O
tumour	tumour	NN	O
cells	cell	NNS	O
.	.	.	O

Cytotoxic	cytotoxic	JJ	O
activity	activity	NN	O
of	of	IN	O
selected	select	VBN	O
compound	compound	NNP	O
3a	3a	NNP	O
and	and	CC	O
cisplatin	cisplatin	VB	O
against	against	IN	O
human	human	JJ	O
embryonic	embryonic	JJ	O
kidney	kidney	NN	O
cell	cell	NN	O
line	line	NN	O
.	.	.	O

To	to	TO	O
evaluate	evaluate	VB	O
whether	whether	IN	O
this	this	DT	O
class	class	NN	O
of	of	IN	O
compounds	compound	NNS	O
target	target	VBP	O
the	the	DT	O
tubulinâmicrotubule	tubulinâmicrotubule	JJ	O
system	system	NN	O
,	,	,	O
compound	compound	NNP	O
3a	3a	NNP	O
,	,	,	O
one	one	CD	O
of	of	IN	O
the	the	DT	O
most	most	RBS	O
active	active	JJ	O
compounds	compound	NNS	O
in	in	IN	O
this	this	DT	O
series	series	NN	O
of	of	IN	O
chalcone	chalcone	NNP	O
derivatives	derivative	NNS	O
,	,	,	O
was	be	VBD	O
chosen	choose	VBN	O
to	to	TO	O
investigate	investigate	VB	O
its	-PRON-	PRP$	O
ability	ability	NN	O
to	to	TO	O
block	block	VB	O
microtubule	microtubule	NNP	O
assembly	assembly	NNP	O
,	,	,	O
with	with	IN	O
colchicine	colchicine	NN	O
as	as	IN	O
the	the	DT	O
reference	reference	NN	O
compound	compound	NN	O
.	.	.	O

As	as	IN	O
shown	show	VBN	O
in	in	IN	O
Figure	Figure	NNP	O
3	3	CD	O
,	,	,	O
compound	compound	NNP	O
3a	3a	NNP	O
inhibited	inhibit	VBD	O
the	the	DT	O
polymerisation	polymerisation	NN	O
of	of	IN	O
tubulin	tubulin	NN	O
in	in	IN	O
a	a	DT	O
concentration	concentration	NN	O
-	-	HYPH	O
dependent	dependent	JJ	O
manner	manner	NN	O
,	,	,	O
which	which	WDT	O
suggests	suggest	VBZ	O
that	that	IN	O
this	this	DT	O
class	class	NN	O
of	of	IN	O
compounds	compound	NNS	O
interfere	interfere	VBP	O
with	with	IN	O
the	the	DT	O
microtubule	microtubule	JJ	O
polymerisation	polymerisation	NN	O
.	.	.	O

Treatment	treatment	NN	O
with	with	IN	O
3.0	3.0	CD	O
,	,	,	O
6.0	6.0	CD	O
,	,	,	O
12.5	12.5	CD	O
,	,	,	O
and	and	CC	O
25âÂµM	25ââµm	CD	O
of	of	IN	O
compound	compound	NNP	O
3a	3a	NNP	O
inhibited	inhibit	VBD	O
tubulin	tubulin	NN	O
polymerisation	polymerisation	NN	O
by	by	IN	O
21	21	CD	O
%	%	NN	O
,	,	,	O
41	41	CD	O
%	%	NN	O
,	,	,	O
60	60	CD	O
%	%	NN	O
,	,	,	O
and	and	CC	O
82	82	CD	O
%	%	NN	O
,	,	,	O
respectively	respectively	RB	O
.	.	.	O

Compound	Compound	NNP	O
3a	3a	NNP	O
was	be	VBD	O
slightly	slightly	RB	O
more	more	RBR	O
active	active	JJ	O
than	than	IN	O
the	the	DT	O
reference	reference	NN	O
compound	compound	NN	O
colchicine	colchicine	NN	O
,	,	,	O
with	with	IN	O
the	the	DT	O
IC50	IC50	NNP	O
values	value	NNS	O
of	of	IN	O
8.4	8.4	CD	O
and	and	CC	O
10.6âÂµM	10.6ââµm	CD	O
,	,	,	O
respectively	respectively	RB	O
.	.	.	O

These	these	DT	O
results	result	NNS	O
indicated	indicate	VBD	O
that	that	IN	O
compound	compound	NNP	O
3a	3a	NNP	O
is	be	VBZ	O
a	a	DT	O
tubulin	tubulin	JJ	O
polymerisation	polymerisation	NN	O
inhibitor	inhibitor	NN	O
,	,	,	O
which	which	WDT	O
can	can	MD	O
bind	bind	VB	O
to	to	IN	O
tubulin	tubulin	NN	O
and	and	CC	O
induces	induce	VBZ	O
microtubule	microtubule	JJ	O
polymerisation	polymerisation	NN	O
.	.	.	O

Tubulin	tubulin	JJ	O
polymerisation	polymerisation	NN	O
inhibitory	inhibitory	NN	O
activity	activity	NN	O
of	of	IN	O
compound	compound	NNP	O
3a	3a	NNP	O
3.0âÎ¼M	3.0âî¼m	CD	O
,	,	,	O
6.0âÎ¼M	6.0âî¼m	NN	O
,	,	,	O
12.5âÎ¼M	12.5âî¼m	CD	O
,	,	,	O
and	and	CC	O
25.0âÎ¼M	25.0âÎ¼M	NNS	O
and	and	CC	O
colchicine	colchicine	NN	O
12.5âÎ¼M	12.5âî¼m	NN	O
.	.	.	O

Many	many	JJ	O
studies	study	NNS	O
have	have	VBP	O
reported	report	VBN	O
that	that	IN	O
tubulin	tubulin	JJ	O
polymerisation	polymerisation	NN	O
inhibitors	inhibitor	NNS	O
can	can	MD	O
arrest	arrest	VB	O
cancer	cancer	NN	O
cells	cell	NNS	O
in	in	IN	O
G2	G2	NNP	O
/	/	SYM	O
M	M	NNP	O
phase	phase	NN	O
and	and	CC	O
lead	lead	VB	O
to	to	IN	O
apoptosis	apoptosis	NN	B
,	,	,	B
.	.	.	O

The	the	DT	O
potent	potent	JJ	O
tubulin	tubulin	JJ	O
polymerisation	polymerisation	NN	O
inhibitory	inhibitory	NN	O
activity	activity	NN	O
of	of	IN	O
compound	compound	NNP	O
3a	3a	NNP	O
promoted	promote	VBD	O
us	-PRON-	PRP	O
to	to	TO	O
further	further	RB	O
investigate	investigate	VB	O
its	-PRON-	PRP$	O
cellular	cellular	JJ	O
mechanisms	mechanism	NNS	O
of	of	IN	O
action	action	NN	O
in	in	IN	O
MCF-7	mcf-7	JJ	O
cancer	cancer	NN	O
cells	cell	NNS	O
by	by	IN	O
using	use	VBG	O
flow	flow	NN	O
cytometry	cytometry	NN	O
analysis	analysis	NN	O
.	.	.	O

In	in	IN	O
order	order	NN	O
to	to	TO	O
elucidate	elucidate	VB	O
the	the	DT	O
molecular	molecular	JJ	O
mechanism	mechanism	NN	O
of	of	IN	O
compound	compound	NNP	O
3a	3a	NNP	O
,	,	,	O
we	-PRON-	PRP	O
first	first	RB	O
studied	study	VBD	O
its	-PRON-	PRP$	O
effect	effect	NN	O
on	on	IN	O
cell	cell	NN	O
cycle	cycle	NN	O
progression	progression	NN	O
in	in	IN	O
MCF-7	MCF-7	NNP	O
cells	cell	NNS	B
.	.	.	O

As	as	IN	O
shown	show	VBN	O
in	in	IN	O
Figure	Figure	NNP	O
4	4	CD	O
,	,	,	O
control	control	NNP	O
group	group	NN	O
show	show	VBP	O
a	a	DT	O
typical	typical	JJ	O
pattern	pattern	NN	O
of	of	IN	O
cell	cell	NN	O
cycle	cycle	NN	O
in	in	IN	O
G1	G1	NNP	O
,	,	,	O
S	S	NNP	O
and	and	CC	O
G2	G2	NNP	O
/	/	SYM	O
M	M	NNP	O
phase	phase	NN	O
.	.	.	O

In	in	IN	O
contrast	contrast	NN	O
,	,	,	O
after	after	IN	O
treatment	treatment	NN	O
of	of	IN	O
MCF-7	MCF-7	NNP	O
cells	cell	NNS	O
with	with	IN	O
compound	compound	NN	O
3a	3a	NNP	O
at	at	IN	O
concentrations	concentration	NNS	O
of	of	IN	O
2.0â¯ÂµM	2.0â¯âµm	CD	O
,	,	,	O
the	the	DT	O
accumulation	accumulation	NN	O
of	of	IN	O
cancer	cancer	NN	O
cells	cell	NNS	O
was	be	VBD	O
detected	detect	VBN	O
at	at	IN	O
G2	G2	NNP	O
/	/	SYM	O
M	M	NNP	O
phase	phase	NN	O
by	by	IN	O
5.5	5.5	CD	O
folds	fold	NNS	O
compared	compare	VBN	O
to	to	IN	O
the	the	DT	O
control	control	NN	O
group	group	NN	O
,	,	,	O
from	from	IN	O
15.19	15.19	CD	O
%	%	NN	O
in	in	IN	O
the	the	DT	O
control	control	NN	O
group	group	NN	O
to	to	IN	O
84.55	84.55	CD	O
%	%	NN	O
in	in	IN	O
the	the	DT	O
compound	compound	NNP	O
3a	3a	NNP	O
treated	treat	VBD	O
group	group	NN	O
.	.	.	O

The	the	DT	O
result	result	NN	O
indicates	indicate	VBZ	O
that	that	IN	O
compound	compound	NN	O
3a	3a	NNP	O
could	could	MD	O
arrest	arrest	VB	O
cells	cell	NNS	O
in	in	IN	O
G2	G2	NNP	O
/	/	SYM	O
M	M	NNP	O
phase	phase	NN	O
and	and	CC	O
halt	halt	VB	O
cell	cell	NN	O
mitosis	mitosis	NN	O
,	,	,	O
which	which	WDT	O
leads	lead	VBZ	O
to	to	IN	O
inhibited	inhibit	VBN	O
MCF-7	MCF-7	NNP	O
cells	cell	NNS	O
proliferation	proliferation	NN	O
.	.	.	O

Cell	cell	NN	O
cycle	cycle	NN	O
analysis	analysis	NN	O
and	and	CC	O
cell	cell	NN	O
apoptosis	apoptosis	NN	O
analysis	analysis	NN	O
for	for	IN	O
MCF-7	MCF-7	NNP	O
cells	cell	NNS	O
.	.	.	O

Induction	induction	NN	O
of	of	IN	O
apoptosis	apoptosis	NN	O
by	by	IN	O
DMSO	DMSO	NNP	O
and	and	CC	O
compound	compound	NNP	O
3a	3a	NNP	O
2.0âÎ¼M	2.0âî¼m	NN	O
;	;	:	O
Cell	cell	NN	O
cycle	cycle	NN	O
analysis	analysis	NN	O
of	of	IN	O
MCF-7	MCF-7	NNP	O
cells	cell	NNS	O
after	after	IN	O
treated	treat	VBN	O
with	with	IN	O
DMSO	DMSO	NNP	O
or	or	CC	O
compound	compound	NNP	O
3a	3a	NNP	O
2.0âÎ¼M	2.0âî¼m	NN	O
for	for	IN	O
24â¯h	24â¯h	CD	O
.	.	.	O

To	to	TO	O
investigate	investigate	VB	O
whether	whether	IN	O
compound	compound	NNP	O
3a	3a	NNP	O
could	could	MD	O
induces	induce	NNS	O
apoptosis	apoptosis	NN	O
,	,	,	O
the	the	DT	O
apoptotic	apoptotic	JJ	O
effect	effect	NN	O
of	of	IN	O
compound	compound	NNP	O
3a	3a	NNP	O
and	and	CC	O
DMSO	DMSO	NNP	O
were	be	VBD	O
evaluated	evaluate	VBN	O
by	by	IN	O
an	an	DT	O
annexin	annexin	NN	O
V	V	NNP	O
FITC	FITC	NNP	O
/	/	SYM	O
PI	PI	NNP	O
dual	dual	JJ	O
staining	staining	NN	O
assay	assay	NN	B
.	.	.	O

After	after	IN	O
treatment	treatment	NN	O
MCF-7	mcf-7	NN	O
cells	cell	NNS	O
with	with	IN	O
compound	compound	NNP	O
3a	3a	NNP	O
at	at	IN	O
the	the	DT	O
concentration	concentration	NN	O
of	of	IN	O
2.0âÂµM	2.0ââµm	CD	O
for	for	IN	O
24âh	24âh	CD	O
,	,	,	O
the	the	DT	O
cells	cell	NNS	O
were	be	VBD	O
labelled	label	VBN	O
with	with	IN	O
the	the	DT	O
two	two	CD	O
dyes	dye	NNS	O
and	and	CC	O
analysed	analyse	VBN	O
by	by	IN	O
flow	flow	NN	O
cytometry	cytometry	NN	O
.	.	.	O

In	in	IN	O
comparison	comparison	NN	O
to	to	IN	O
the	the	DT	O
DMSO	DMSO	NNP	O
control	control	NN	O
group	group	NN	O
,	,	,	O
it	-PRON-	PRP	O
was	be	VBD	O
observed	observe	VBN	O
that	that	IN	O
compound	compound	NN	O
3a	3a	NNP	O
could	could	MD	O
induce	induce	VB	O
an	an	DT	O
increase	increase	NN	O
in	in	IN	O
the	the	DT	O
late	late	JJ	O
/	/	SYM	O
secondary	secondary	JJ	O
cellular	cellular	JJ	O
apoptosis	apoptosis	NN	O
from	from	IN	O
0.68	0.68	CD	O
%	%	NN	O
to	to	IN	O
6.34	6.34	CD	O
%	%	NN	O
.	.	.	O

In	in	IN	O
addition	addition	NN	O
,	,	,	O
an	an	DT	O
increase	increase	NN	O
in	in	IN	O
the	the	DT	O
early	early	JJ	O
/	/	SYM	O
primary	primary	JJ	O
apoptosis	apoptosis	NN	O
was	be	VBD	O
also	also	RB	O
observed	observe	VBN	O
from	from	IN	O
1.85	1.85	CD	O
%	%	NN	O
to	to	IN	O
20.0	20.0	CD	O
%	%	NN	O
.	.	.	O

Collectively	collectively	RB	O
,	,	,	O
these	these	DT	O
results	result	NNS	O
confirmed	confirm	VBD	O
that	that	IN	O
this	this	DT	O
series	series	NN	O
of	of	IN	O
compounds	compound	NNS	O
could	could	MD	O
arrest	arrest	VB	O
cells	cell	NNS	O
in	in	IN	O
G2	G2	NNP	O
/	/	SYM	O
M	M	NNP	O
phase	phase	NN	O
and	and	CC	O
induce	induce	VB	O
apoptotic	apoptotic	JJ	O
cell	cell	NN	O
death	death	NN	O
.	.	.	O

To	to	TO	O
explain	explain	VB	O
the	the	DT	O
binding	bind	VBG	O
modes	mode	NNS	O
of	of	IN	O
this	this	DT	O
class	class	NN	O
of	of	IN	O
compounds	compound	NNS	O
with	with	IN	O
tubulin	tubulin	NNP	O
,	,	,	O
we	-PRON-	PRP	O
performed	perform	VBD	O
a	a	DT	O
docking	docking	NN	O
study	study	NN	O
of	of	IN	O
the	the	DT	O
most	most	RBS	O
active	active	JJ	O
compound	compound	NN	O
3a	3a	NNP	O
into	into	IN	O
the	the	DT	O
colchicine	colchicine	NN	O
binding	bind	VBG	O
pocket	pocket	NN	O
of	of	IN	O
tubulin	tubulin	NN	O
by	by	IN	O
using	use	VBG	O
the	the	DT	O
Autodock	Autodock	NNP	O
vina	vina	NN	O
1.1.2	1.1.2	NN	O
software	software	NN	B
.	.	.	O

The	the	DT	O
result	result	NN	O
was	be	VBD	O
shown	show	VBN	O
in	in	IN	O
Figure	Figure	NNP	O
5	5	CD	O
and	and	CC	O
the	the	DT	O
estimated	estimate	VBN	O
binding	bind	VBG	O
energy	energy	NN	O
was	be	VBD	O
â8.8âkcalÂ·molâ1	â8.8âkcalâ·molâ1	NN	O
.	.	.	O

Compound	Compound	NNP	O
3a	3a	NNP	O
adopted	adopt	VBD	O
a	a	DT	O
âL	âL	NNP	O
-	-	HYPH	O
shapedâ	shapedâ	JJS	O
conformation	conformation	NN	O
in	in	IN	O
the	the	DT	O
pocket	pocket	NN	O
of	of	IN	O
the	the	DT	O
tubulin	tubulin	NN	O
.	.	.	O

The	the	DT	O
2-methoxynaphthyl	2-methoxynaphthyl	CD	O
group	group	NN	O
of	of	IN	O
3a	3a	NNP	O
located	locate	VBN	O
at	at	IN	O
the	the	DT	O
hydrophobic	hydrophobic	NNP	O
pocket	pocket	NNP	O
,	,	,	O
surrounded	surround	VBN	O
by	by	IN	O
the	the	DT	O
residues	residue	NNS	O
Cys-241	Cys-241	NNP	O
,	,	,	O
Leu-248	leu-248	CD	O
,	,	,	O
Ala-250	ala-250	CD	O
,	,	,	O
Leu-252	leu-252	CD	O
,	,	,	O
and	and	CC	O
Leu-255	leu-255	CD	O
,	,	,	O
forming	form	VBG	O
a	a	DT	O
strong	strong	JJ	O
hydrophobic	hydrophobic	NN	O
binding	binding	NN	O
.	.	.	O

Detailed	detailed	JJ	O
analysis	analysis	NN	O
showed	show	VBD	O
that	that	IN	O
the	the	DT	O
phenyl	phenyl	NNP	O
group	group	NN	O
in	in	IN	O
the	the	DT	O
middle	middle	NN	O
of	of	IN	O
3a	3a	NNP	O
formed	form	VBD	O
a	a	DT	O
cation	cation	NN	O
-	-	HYPH	O
Ï	ï	JJ	O
interaction	interaction	NN	O
with	with	IN	O
the	the	DT	O
residue	residue	NN	O
Lys-254	Lys-254	NNP	O
.	.	.	O

It	-PRON-	PRP	O
was	be	VBD	O
shown	show	VBN	O
that	that	IN	O
the	the	DT	O
residues	residue	NNS	O
Gln-11	Gln-11	NNP	O
bond	bond	NN	O
length	length	NN	O
:	:	:	O
3.4âÃ	3.4âã	CD	O
		_SP	O
,	,	,	O
Leu-248	leu-248	CD	O
bond	bond	NN	O
length	length	NN	O
:	:	:	O
3.0âÃ	3.0âÃ	NNP	O
		_SP	O
,	,	,	O
and	and	CC	O
Leu-255	Leu-255	NNP	O
bond	bond	NN	O
length	length	NN	O
:	:	:	O
3.1âÃ	3.1âÃ	NNP	O
		_SP	O
formed	form	VBD	O
three	three	CD	O
hydrogen	hydrogen	NN	O
bond	bond	NN	O
interactions	interaction	NNS	O
with	with	IN	O
3a	3a	NNP	O
,	,	,	O
which	which	WDT	O
was	be	VBD	O
the	the	DT	O
main	main	JJ	O
interaction	interaction	NN	O
between	between	IN	O
3a	3a	NNP	O
and	and	CC	O
tubulin	tubulin	NN	O
.	.	.	O

The	the	DT	O
binding	bind	VBG	O
mode	mode	NN	O
of	of	IN	O
compound	compound	NN	O
3a	3a	NNP	O
with	with	IN	O
colchicine	colchicine	NN	O
binding	bind	VBG	O
site	site	NN	O
of	of	IN	O
tubulin	tubulin	NN	O
.	.	.	O

Hydrogen	hydrogen	NN	O
bonding	bonding	NN	O
was	be	VBD	O
depicted	depict	VBN	O
as	as	IN	O
yellow	yellow	JJ	O
dotted	dotted	JJ	O
lines	line	NNS	O
.	.	.	O

In	in	IN	O
summary	summary	NN	O
,	,	,	O
we	-PRON-	PRP	O
designed	design	VBD	O
and	and	CC	O
synthesised	synthesise	VBD	O
a	a	DT	O
series	series	NN	O
of	of	IN	O
naphthalene	naphthalene	NN	O
-	-	HYPH	O
chalcone	chalcone	NN	O
derivatives	derivative	NNS	O
3aâ3	3aâ3	CD	O
t	t	NN	O
as	as	IN	O
tubulin	tubulin	NN	O
polymerisation	polymerisation	NN	O
inhibitors	inhibitor	NNS	O
for	for	IN	O
the	the	DT	O
treatment	treatment	NN	O
of	of	IN	O
breast	breast	NN	O
cancer	cancer	NN	O
.	.	.	O

Among	among	IN	O
them	-PRON-	PRP	O
,	,	,	O
compound	compound	NNP	O
3a	3a	CD	O
bearing	bear	VBG	O
3-hydroxyl-4-methoxy	3-hydroxyl-4-methoxy	CD	O
phenyl	phenyl	NNP	O
moiety	moiety	NN	O
was	be	VBD	O
found	find	VBN	O
to	to	TO	O
be	be	VB	O
the	the	DT	O
most	most	RBS	O
active	active	JJ	O
compound	compound	NN	O
,	,	,	O
with	with	IN	O
an	an	DT	O
IC50	IC50	NNP	O
value	value	NN	O
of	of	IN	O
1.42âÂ±â0.15âÂµM	1.42ââ±â0.15ââµm	CD	O
against	against	IN	O
MCF-7	MCF-7	NNP	O
breast	breast	NN	O
cancer	cancer	NN	O
cell	cell	NN	O
line	line	NN	O
.	.	.	O

The	the	DT	O
promising	promising	JJ	O
compound	compound	NN	O
3a	3a	NNP	O
demonstrated	demonstrate	VBD	O
relatively	relatively	RB	O
lower	low	JJR	O
cytotoxicity	cytotoxicity	NN	O
on	on	IN	O
normal	normal	JJ	O
cell	cell	NN	O
line	line	NN	O
compared	compare	VBN	O
to	to	IN	O
tumour	tumour	VB	O
cell	cell	NN	O
line	line	NN	O
.	.	.	O

Additionally	additionally	RB	O
,	,	,	O
in	in	IN	O
mechanistic	mechanistic	JJ	O
studies	study	NNS	O
,	,	,	O
the	the	DT	O
representative	representative	JJ	O
compound	compound	NNP	O
3a	3a	NNP	O
was	be	VBD	O
found	find	VBN	O
to	to	TO	O
induce	induce	VB	O
significant	significant	JJ	O
cell	cell	NN	O
cycle	cycle	NN	O
arrest	arrest	NN	O
at	at	IN	O
the	the	DT	O
G2	G2	NNP	O
/	/	SYM	O
M	M	NNP	O
phase	phase	NN	O
and	and	CC	O
cell	cell	NN	O
apoptosis	apoptosis	NN	O
in	in	IN	O
MCF-7	mcf-7	JJ	O
cell	cell	NN	O
lines	line	NNS	O
.	.	.	O

Notably	notably	RB	O
,	,	,	O
compound	compound	NNP	O
3a	3a	NNP	O
also	also	RB	O
displayed	display	VBD	O
potent	potent	JJ	O
tubulin	tubulin	JJ	O
polymerisation	polymerisation	NN	O
inhibitory	inhibitory	NN	O
activity	activity	NN	O
with	with	IN	O
an	an	DT	O
IC50	IC50	NNP	O
value	value	NN	O
of	of	IN	O
8.4â¯ÂµM	8.4â¯âµm	NN	O
,	,	,	O
which	which	WDT	O
was	be	VBD	O
slightly	slightly	RB	O
more	more	RBR	O
active	active	JJ	O
than	than	IN	O
the	the	DT	O
reference	reference	NN	O
compound	compound	NN	O
colchicine	colchicine	NN	O
IC50â¯=â¯10.6âÂµM	IC50â¯=â¯10.6âÂµM	NNP	O
.	.	.	O

Furthermore	furthermore	RB	O
,	,	,	O
molecular	molecular	JJ	O
docking	docking	NN	O
studies	study	NNS	O
revealed	reveal	VBD	O
that	that	IN	O
these	these	DT	O
compounds	compound	NNS	O
can	can	MD	O
bind	bind	VB	O
at	at	IN	O
the	the	DT	O
colchicine	colchicine	NN	O
binding	bind	VBG	O
site	site	NN	O
of	of	IN	O
the	the	DT	O
tubulin	tubulin	NN	O
.	.	.	O

